Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS Metastases

Detalles Bibliográficos
Autores principales: Andreev-Drakhlin, Alexander, Cabanillas, Maria, Amini, Behrang, Subbiah, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608524/
https://www.ncbi.nlm.nih.gov/pubmed/33154983
http://dx.doi.org/10.1200/PO.20.00096
_version_ 1783604858585088000
author Andreev-Drakhlin, Alexander
Cabanillas, Maria
Amini, Behrang
Subbiah, Vivek
author_facet Andreev-Drakhlin, Alexander
Cabanillas, Maria
Amini, Behrang
Subbiah, Vivek
author_sort Andreev-Drakhlin, Alexander
collection PubMed
description
format Online
Article
Text
id pubmed-7608524
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-76085242020-11-04 Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS Metastases Andreev-Drakhlin, Alexander Cabanillas, Maria Amini, Behrang Subbiah, Vivek JCO Precis Oncol Case Reports American Society of Clinical Oncology 2020-10-30 /pmc/articles/PMC7608524/ /pubmed/33154983 http://dx.doi.org/10.1200/PO.20.00096 Text en © 2020 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/ Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Case Reports
Andreev-Drakhlin, Alexander
Cabanillas, Maria
Amini, Behrang
Subbiah, Vivek
Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS Metastases
title Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS Metastases
title_full Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS Metastases
title_fullStr Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS Metastases
title_full_unstemmed Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS Metastases
title_short Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS Metastases
title_sort systemic and cns activity of selective ret inhibition with selpercatinib (loxo-292) in a patient with ret-mutant medullary thyroid cancer with extensive cns metastases
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608524/
https://www.ncbi.nlm.nih.gov/pubmed/33154983
http://dx.doi.org/10.1200/PO.20.00096
work_keys_str_mv AT andreevdrakhlinalexander systemicandcnsactivityofselectiveretinhibitionwithselpercatinibloxo292inapatientwithretmutantmedullarythyroidcancerwithextensivecnsmetastases
AT cabanillasmaria systemicandcnsactivityofselectiveretinhibitionwithselpercatinibloxo292inapatientwithretmutantmedullarythyroidcancerwithextensivecnsmetastases
AT aminibehrang systemicandcnsactivityofselectiveretinhibitionwithselpercatinibloxo292inapatientwithretmutantmedullarythyroidcancerwithextensivecnsmetastases
AT subbiahvivek systemicandcnsactivityofselectiveretinhibitionwithselpercatinibloxo292inapatientwithretmutantmedullarythyroidcancerwithextensivecnsmetastases

Ejemplares similares